Drug Shortage Report for MYLAN-PANTOPRAZOLE

Last updated on 2018-07-05 History
Report ID 200
Drug Identification Number 02299585
Brand name MYLAN-PANTOPRAZOLE
Common or Proper name PANTOPRAZOLE
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) PANTOPRAZOLE
Strength(s) 40MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL
Packaging size 500BT, 100BT
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-07-03
Actual start date 2018-07-03
Estimated end date Unknown
Actual end date 2018-07-03
Shortage status Resolved
Updated date 2018-07-05
Company comments Discontinued in ID 51513
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v32 2017-10-26 French Compare
v31 2017-10-26 English Compare
v30 2017-10-26 English Compare
v29 2017-10-24 French Compare
v28 2017-10-24 English Compare
v27 2017-10-23 French Compare
v26 2017-10-23 English Compare
v25 2017-10-19 French Compare
v24 2017-10-19 English Compare
v23 2017-10-18 English Compare
v22 2017-10-13 French Compare
v21 2017-10-13 English Compare
v20 2017-10-05 English Compare
v19 2017-09-28 French Compare
v18 2017-09-28 English Compare
v17 2017-09-28 French Compare
v16 2017-09-28 English Compare
v15 2017-09-08 French Compare
v14 2017-09-08 English Compare
v13 2017-09-08 English Compare

Showing 41 to 60 of 72